A S Horn|J R Rodgers - JoVE Visualize

Showing results (71-80 of 128) with videos related to

Pageof 13

Sort By:

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 1, 1997

p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomasP E O'Reilly, S S Raab, T H Niemann, et al.

The Journal of Experimental Medicine|October 1, 1991

Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic originS M Shawar, J M Vyas, J R Rodgers, et al.

The Journal of Experimental Medicine|January 1, 1994

Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimeraJ M Vyas, R R Rich, D D Howell, et al.

Human Pathology|April 1, 1995

p53 protein overexpression in smooth muscle tumors of the uterusT H Niemann, S S Raab, J C Lenel, et al.

The Journal of Pharmacy and Pharmacology|January 1, 1991

Orally active carbamate prodrugs of the selective dopamine agonist N-0437: in-vivo activities in the 6-OHDA turning model and in-vitro activitiesI den Daas, P de Boer, P G Tepper, et al.

Fundamental & Clinical Pharmacology|January 1, 1988

Pharmacokinetics and pharmacodynamics of 2,4-diaminopyridine in the catP T Biessels, M C Houwertjes, A H Scaf, et al.

Life Sciences|March 21, 1983

In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTNM G Feenstra, H Rollema, T B Mulder, et al.

European Journal of Pharmacology|February 26, 1985

N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting propertiesB Hazelhoff, J B De Vries, D Dijkstra, et al.

European Journal of Pharmacology|June 17, 1986

Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734J Van der Weide, J B De Vries, P G Tepper, et al.

Journal of Medicinal Chemistry|October 1, 1993

2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agentsS Copinga, P G Tepper, C J Grol, et al.

Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:

Pageof 13

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 1, 1997

p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomasP E O'Reilly, S S Raab, T H Niemann, et al.

The Journal of Experimental Medicine|October 1, 1991

Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic originS M Shawar, J M Vyas, J R Rodgers, et al.

The Journal of Experimental Medicine|January 1, 1994

Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimeraJ M Vyas, R R Rich, D D Howell, et al.

Human Pathology|April 1, 1995

p53 protein overexpression in smooth muscle tumors of the uterusT H Niemann, S S Raab, J C Lenel, et al.

The Journal of Pharmacy and Pharmacology|January 1, 1991

Orally active carbamate prodrugs of the selective dopamine agonist N-0437: in-vivo activities in the 6-OHDA turning model and in-vitro activitiesI den Daas, P de Boer, P G Tepper, et al.

Fundamental & Clinical Pharmacology|January 1, 1988

Pharmacokinetics and pharmacodynamics of 2,4-diaminopyridine in the catP T Biessels, M C Houwertjes, A H Scaf, et al.

Life Sciences|March 21, 1983

In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTNM G Feenstra, H Rollema, T B Mulder, et al.

European Journal of Pharmacology|February 26, 1985

N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting propertiesB Hazelhoff, J B De Vries, D Dijkstra, et al.

European Journal of Pharmacology|June 17, 1986

Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734J Van der Weide, J B De Vries, P G Tepper, et al.

Journal of Medicinal Chemistry|October 1, 1993

2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agentsS Copinga, P G Tepper, C J Grol, et al.

Pageof 13